6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
6m ago	Zacks Small-Cap Research Raises FatPipe (NASDAQ:FATN) Valuation from $6.00 to $6.40 per Share Following Preliminary Fiscal Fourth Quarter Business Update
6m ago	MEDX HOLDINGS ANNOUNCES Q1 2026 HIGHLIGHTS, MULTI-CITY EXPANSION, AND CORPORATE ACTION TO REBRAND AS DAZED INC. (TICKER: DAZE)
6m ago	VS Media Enters the AI Smart Living Sector to Explore New Growth Opportunities
32m ago	Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch
33m ago	Surface Transforms plc – in Administration, Sale of Business and Assets

About

26.17USD+0.61 +2.37%

Closed • Updated at 17:08 GMT+00:00

Market Cap$1.81B

Volume55.4K

Beta0.80

RSI61.40

Gross Margin-159.12%

Health TechnologyMedical Specialties

Pulse Biosciences, Inc — investor relations, events, news, and company updates on 6ix.

Latest News

ATM Equity Purchases by Pulse Biosciences’ Co-Chairmen Total Approximately $13.3 Million

Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference

Turbett Surgical Appoints Kevin Danahy as President and Chief Executive Officer to Lead Growth Phase

Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results

Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026

Community Chat

Ask AI